The current study proposes a binary classification of TGF-β/Smad pathway activity as either high or low, aiming to elucidate the divergent connections between various allergic diseases and the risk of cancer, as well as their contrasting association with metabolic dysregulations. The gene discussed is TGFB1; the disease is cancer.